Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 73 to 75 of 75 entries
Sorted by: Best Match Show Resources per page
Proteomic Dissection of the Impact of Environmental Exposures on Mouse Seminal Vesicle Function.

Molecular & cellular proteomics : MCP

Skerrett-Byrne DA, Trigg NA, Bromfield EG, Dun MD, Bernstein IR, Anderson AL, Stanger SJ, MacDougall LA, Lord T, Aitken RJ, Roman SD, Robertson SA, Nixon B, Schjenken JE.
PMID: 34089863
Mol Cell Proteomics. 2021;20:100107. doi: 10.1016/j.mcpro.2021.100107. Epub 2021 Jun 02.

Seminal vesicles are an integral part of the male reproductive accessory gland system. They produce a complex array of secretions containing bioactive constituents that support gamete function and promote reproductive success, with emerging evidence suggesting these secretions are influenced...

Cite
Skerrett-Byrne DA, Trigg NA, Bromfield EG, et al. Proteomic Dissection of the Impact of Environmental Exposures on Mouse Seminal Vesicle Function. Mol Cell Proteomics. 2021;20:100107doi: 10.1016/j.mcpro.2021.100107.
Skerrett-Byrne, D. A., Trigg, N. A., Bromfield, E. G., Dun, M. D., Bernstein, I. R., Anderson, A. L., Stanger, S. J., MacDougall, L. A., Lord, T., Aitken, R. J., Roman, S. D., Robertson, S. A., Nixon, B., & Schjenken, J. E. (2021). Proteomic Dissection of the Impact of Environmental Exposures on Mouse Seminal Vesicle Function. Molecular & cellular proteomics : MCP, 20100107. https://doi.org/10.1016/j.mcpro.2021.100107
Skerrett-Byrne, David A, et al. "Proteomic Dissection of the Impact of Environmental Exposures on Mouse Seminal Vesicle Function." Molecular & cellular proteomics : MCP vol. 20 (2021): 100107. doi: https://doi.org/10.1016/j.mcpro.2021.100107
Skerrett-Byrne DA, Trigg NA, Bromfield EG, Dun MD, Bernstein IR, Anderson AL, Stanger SJ, MacDougall LA, Lord T, Aitken RJ, Roman SD, Robertson SA, Nixon B, Schjenken JE. Proteomic Dissection of the Impact of Environmental Exposures on Mouse Seminal Vesicle Function. Mol Cell Proteomics. 2021;20:100107. doi: 10.1016/j.mcpro.2021.100107. Epub 2021 Jun 02. PMID: 34089863; PMCID: PMC8250459.
Copy Download .nbib Format: NLM
Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study.

Multiple sclerosis and related disorders

Smets I, Holden D, Bianchi L, Ammoscato F, Allen-Philbey K, Baker D, Turner B, Marta M, Giovannoni G, Macdougall A, Schmierer K, Hobart J, Gnanapavan S.
PMID: 34871856
Mult Scler Relat Disord. 2021 Nov 22;57:103409. doi: 10.1016/j.msard.2021.103409. Epub 2021 Nov 22.

BACKGROUND: In multiple sclerosis (MS) neurofilament light chain (NfL) is a marker of neuronal damage secondary to inflammation and neurodegeneration. NfL levels drop after commencement of disease-modifying treatment, especially the highly active ones. However, the factors that influence this...

Cite
Smets I, Holden D, Bianchi L, et al. Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study. Mult Scler Relat Disord. 2021;57:103409doi: 10.1016/j.msard.2021.103409.
Smets, I., Holden, D., Bianchi, L., Ammoscato, F., Allen-Philbey, K., Baker, D., Turner, B., Marta, M., Giovannoni, G., Macdougall, A., Schmierer, K., Hobart, J., & Gnanapavan, S. (2021). Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study. Multiple sclerosis and related disorders, 57103409. https://doi.org/10.1016/j.msard.2021.103409
Smets, Ide, et al. "Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study." Multiple sclerosis and related disorders vol. 57 (2021): 103409. doi: https://doi.org/10.1016/j.msard.2021.103409
Smets I, Holden D, Bianchi L, Ammoscato F, Allen-Philbey K, Baker D, Turner B, Marta M, Giovannoni G, Macdougall A, Schmierer K, Hobart J, Gnanapavan S. Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study. Mult Scler Relat Disord. 2021 Nov 22;57:103409. doi: 10.1016/j.msard.2021.103409. Epub 2021 Nov 22. PMID: 34871856.
Copy Download .nbib Format: NLM
Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study.

Multiple sclerosis and related disorders

Smets I, Holden D, Bianchi L, Ammoscato F, Allen-Philbey K, Baker D, Turner B, Marta M, Giovannoni G, Macdougall A, Schmierer K, Hobart J, Gnanapavan S.
PMID: 34871856
Mult Scler Relat Disord. 2021 Nov 22;57:103409. doi: 10.1016/j.msard.2021.103409. Epub 2021 Nov 22.

BACKGROUND: In multiple sclerosis (MS) neurofilament light chain (NfL) is a marker of neuronal damage secondary to inflammation and neurodegeneration. NfL levels drop after commencement of disease-modifying treatment, especially the highly active ones. However, the factors that influence this...

Cite
Smets I, Holden D, Bianchi L, et al. Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study. Mult Scler Relat Disord. 2021;57:103409doi: 10.1016/j.msard.2021.103409.
Smets, I., Holden, D., Bianchi, L., Ammoscato, F., Allen-Philbey, K., Baker, D., Turner, B., Marta, M., Giovannoni, G., Macdougall, A., Schmierer, K., Hobart, J., & Gnanapavan, S. (2021). Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study. Multiple sclerosis and related disorders, 57103409. https://doi.org/10.1016/j.msard.2021.103409
Smets, Ide, et al. "Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study." Multiple sclerosis and related disorders vol. 57 (2021): 103409. doi: https://doi.org/10.1016/j.msard.2021.103409
Smets I, Holden D, Bianchi L, Ammoscato F, Allen-Philbey K, Baker D, Turner B, Marta M, Giovannoni G, Macdougall A, Schmierer K, Hobart J, Gnanapavan S. Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study. Mult Scler Relat Disord. 2021 Nov 22;57:103409. doi: 10.1016/j.msard.2021.103409. Epub 2021 Nov 22. PMID: 34871856.
Copy Download .nbib Format: NLM
Showing 73 to 75 of 75 entries